SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (165)12/10/2003 11:49:10 PM
From: mopgcw  Read Replies (1) of 411
 
In the "No S***" Category w/ 1st Albany:

CV Therapeutics Cut to `Underperform' at Bear Stearns :CVTX US
2003-12-10 10:55 (New York)

Princeton, New Jersey, Dec. 10 (Bloomberg Data) -- CV Therapeutics Inc.
(CVTX US) was downgraded to ``underperform'' from ``peer perform'' by analyst
Akhtar Samad at Bear Stearns & Co.

And not to be left out:

CV Therapeutics Cut to `Hold' at Deutsche Bank :CVTX US
2003-12-10 13:17 (New York)

Princeton, New Jersey, Dec. 10 (Bloomberg Data) -- CV Therapeutics Inc.
(CVTX US) was downgraded to ``hold'' from ``buy'' by analyst Dennis R Harp at
Deutsche Bank. The target price is $14 per share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News